Results 41 to 50 of about 100,511 (312)

Antiarrhythmic mechanisms of beta blocker therapy.

Pharmacological Research, 2019
Sympathetic activity plays an important role in modulation of cardiac rhythm. Indeed, while exerting positive tropic effects in response to physiologic and pathologic stressors, β-adrenergic stimulation influences cardiac electrophysiology and can lead ...
E. Grandi, C. M. Ripplinger
semanticscholar   +1 more source

2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Circulation, 2018
Antiarrhythmic medications are commonly administered during and immediately after a ventricular fibrillation/pulseless ventricular tachycardia cardiac arrest. However, it is unclear whether these medications improve patient outcomes.
A. Panchal, K. Berg, P. Kudenchuk, Marina del Rios, K. Hirsch, M. Link, M. Kurz, P. Chan, J. Cabañas, P. Morley, M. Hazinski, M. Donnino   +11 more
semanticscholar   +1 more source

The current approach of atrial fibrillation management

Avicenna Journal of Medicine, 2016
Atrial fibrillation (AF) is the most commonly encountered arrhythmia in clinical practice. Aging populations coupled with improved outcomes for many chronic medical conditions has led to increases in AF diagnoses.
Anish Amin, Aseel Houmsse, Abiodun Ishola, Jaret Tyler, Mahmoud Houmsse   +4 more
doaj   +1 more source

European Resuscitation Council Guidelines for Resuscitation: 2018 Update - Antiarrhythmic drugs for cardiac arrest.

Resuscitation, 2019
This European Resuscitation Council (ERC) Guidelines for Resuscitation 2018 update is focused on the role of antiarrhythmic drugs during advanced life support for cardiac arrest with shock refractory ventricular fibrillation/pulseless ventricular ...
J. Soar, G. Perkins, I. Maconochie, B. Böttiger, C. Deakin, C. Sandroni, T. Olasveengen, J. Wyllie, R. Greif, A. Lockey, F. Semeraro, P. Van de Voorde, C. Lott, L. Bossaert, K. Monsieurs, J. Nolan   +15 more
semanticscholar   +1 more source

Long‐Term Outcomes With Class 1C Antiarrhythmic Drug Use in Atrial Fibrillation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Rhythm control with class 1C antiarrhythmic drugs (AADs) is a widely used treatment among patients with atrial fibrillation (AF), but cardiovascular benefits of class 1C pharmacotherapy over rate control strategy are still unclear.
Aditya Bhonsale, Yisi Wang, Floyd Thoma, Krishna Kancharla, Andrew Voigt, Alaa Shalaby, Aditi Naniwadekar, Virginia Singla, N. A. Estes, Samir Saba, Suresh Mulukutla, Sandeep Jain   +11 more
doaj   +1 more source

The year in cardiology: arrhythmias and pacing. [PDF]

, 2020
During this last year, there has been much progress with regard to anticoagulant and ablation therapy for atrial fibrillation (AF). Apart from recently issued European Society of Cardiology Guidelines for the management of patients with supraventricular ...
Calkins, H, Camm, AJ, Lip, GYH, Schilling, R, Steffel, J   +4 more
core   +4 more sources

Historical Aspects of the Use of Antiarrhythmic Drugs in Clinical Practice

Рациональная фармакотерапия в кардиологии, 2022
Heart rhythm disorders are one of the most urgent problems in cardiology. The first reports on the possibility of using drugs in the treatment of cardiac arrhythmias began to appear in the scientific literature from the middle of the 18th century.
V. L. Doshchitsin, A. I. Tarzimanova
doaj   +1 more source

Effect of catheter ablation on quality of life in patients with atrial fibrillation and its correlation with arrhythmia outcome [PDF]

, 2015
Objective To assess the effect of catheter ablation on atrial fibrillation (AF) symptoms and quality of life (QoL). Methods Patients with AF scheduled for ablation were recruited.
Bourke, John P, Langley, Philip, Lord, Stephen, Murray, Alan, Murray, Stephen, Raine, Daniel, Shepherd, Ewen   +6 more
core   +1 more source

Association of Rate‐Control and Antiarrhythmic Medication Use and Risk of Ischemic Stroke and Death in Patients on Dialysis With Atrial Fibrillation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Incident atrial fibrillation (AF) is common among adults with kidney failure treated with maintenance dialysis and is associated with poor clinical outcomes. Limited data exist informing treatment of AF among patients on dialysis.
Benjamin Lidgard, Dongjie X. Fan, Leila R. Zelnick, Jaejin An, Teresa N. Harrison, Ming‐Sum Lee, Daniel Singer, Grace H. Tabada, Alan S. Go, Nisha Bansal   +9 more
doaj   +1 more source

Fatty acid analogue N-arachidonoyl taurine restores function of IKs channels with diverse long QT mutations

eLife, 2016
About 300 loss-of-function mutations in the IKs channel have been identified in patients with Long QT syndrome and cardiac arrhythmia. How specific mutations cause arrhythmia is largely unknown and there are no approved IKs channel activators for ...
Sara I Liin, Johan E Larsson, Rene Barro-Soria, Bo Hjorth Bentzen, H Peter Larsson   +4 more
doaj   +1 more source